Funding for this research was provided by:
The National Key R&D Program of China (2020YFA0908000)
Tianjin Synthetic Biotechnology Innovation Capacity Improvement Project (TSBICIP-CXRC-001)
Key project at central government level: The ability establishment of sustainable use for valuable Chinese medicine resource (2060302)
Article History
Received: 24 August 2023
Revised: 25 April 2024
Accepted: 25 April 2024
First Online: 23 May 2024
Declarations
: The authors declare no competing interests and this article does not contain any studies with human participants or animals performed by any of the authors.